Snapshot

Updates from your followed companies

US Cancer Immunotherapy Forecast and Company Analysis Report 2025-2033 Featuring Amgen, AstraZeneca, Bayer, Bristol-Myers Squibb, Pfizer, Novartis, Johnson & Johnson, Eli Lily Co, Seattle Genetics - ResearchAndMarkets.com

The "United States Cancer Immunotherapy Market Report by Products, Application, End User, States and Company Analysis...

Californiaconsumerbanking

Essential Thrombocythemia Market to Grow Significantly from $417 Million in 2024, Driven by Shifts Toward Targeted Therapies and Precision Medicine, finds DelveInsight | pharma&, AOP Orphan Pharmaceuticals, Merck Sharp & Dohme, Novartis, Incyte, PharmaEss

The Essential Thrombocythemia market, valued at $417M in 2024 across the 7MM, is set for major growth through 2034, w...

Openpr

Pediatric Palliative Care Drugs Market Is Booming Worldwide | Novartis International AG, Mylan NV, Teva Pharmaceutical Industries Ltd.

The Pediatric Palliative Care Drugs market is estimated to be valued at USD 91.79 Bn in 2025 and is expected to reach...

Openpr

Recommended Companies Like what you see? Companies in this section will change, so be sure to follow companies that matter to you to receive regular updates. Learn more about following companies

Court Rejects Pfizer's Bid To Block Metsera Board From Considering Novo Nordisk's $10 Bln Offer

(RTTNews) - Metsera Inc. (MTSR) released a statement after the Delaware Court of Chancery rejected Pfizer Inc.'s (PFE...

Nasdaq

MSD secures $700 million boost from Blackstone to advance broad-cancer ADC therapy Sac-TMT

Indian Pharma Post

Lilly, Novo Nordisk Among Latest Pharma Giants To Commit To Trump's MFN Drug Pricing Policy

INDIANAPOLIS (dpa-AFX) - Eli Lilly and Co. (LLY) and Novo Nordisk A/S (NVO) are the latest to reach an agreement with...

FinanzNachrichten

FDA Approves J&J' Caplyta As Add-On Therapy For Major Depressive Disorder In Adults

NEW BRUNSWICK (dpa-AFX) - Johnson & Johnson (JNJ) on Thursday announced that the U.S. Food and Drug Administration (F...

FinanzNachrichten

Abbott India Q2 PAT jumps 16% YoY to Rs 415 cr

Abbott India's standalone net profit climbed 15.79% to Rs 415.27 crore on 7.62% increase in revenue from operations t...

Business Standard

AstraZeneca Builds Obesity Pipeline On 'Medical Aspect,' Not Aesthetics

In an investor call Thursday, AstraZeneca CEO Pascal Soriot outlined his company's approach to obesity drug developme...

BioSpace

Stock Of The Day: Will Amgen Reverse Again?

Amgen shares gained almost 8% on Wednesday after the company released earnings. The firm has now reached a critical p...

Benzinga

Billie Jean King supports Medtronic Diabetes awareness initiative

The annual Medtronic (NYSE:MDT) diabetes awareness initiative this year has the backing of sporting legend Billie Jea...

Drug Delivery Business

Teva's revenue changed from $16.63B in Jun 2025 to $16.78B in Sep 2025

Teva’s Trailing Twelve Months revenue changed from $16.63B in Jun 2025 to $16.78B in Sep 2025 increasing 0.9% in this...

Owler

WHO & Bayer AG renew longstanding collaboration to eliminate three deadly neglected tropical diseases

The World Health Organization (WHO) and the German pharmaceutical company, Bayer AG, have renewed a longstanding coll...

Pharmabiz

Pfizer beats out Novo in bidding war for obesity-drug startup Metsera

Pfizer has won the bidding war against Novo Nordisk to acquire obesity-drug biotech Metsera

STAT News

Ailux announces strategic collaboration with Lilly to advance bispecific antibody development

Ailux, an innovator in AI─powered biologics and a wholly owned subsidiary of XtalPi, a global leader in AI drug disco...

Pharmabiz

[CIIE] AstraZeneca to Pour USD136 Million More Into Aerosol Drug Plant in Qingdao

Yicai Global

Pfizer sues Novo Nordisk and Metsera in bidding war

Pfizer has filed two lawsuits against the metabolic-focused startup Metsera and Novo Nordisk as of Tuesday. The first...

Drug Discovery & Development